P&R Bidco
The computed 12-month bankruptcy probability of P&R Bidco is 1.7% (moderate). The 2024 annual accounts show equity of €7.93M and a net result of €-134k. Equity remains stable across the filed fiscal years (±1.9% per year). Its solvency ranks better than 81% of 972 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €7.93M |
| Net result | €-134k |
| Better than sector | 81% |
| Active | 4 yrs |
Mixed profile: strong on stability, weaker on profitability.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 64.1% | 27.2% | |
| Net result | €-134k | €23k | |
| Equity | €7.93M | €171k | |
| Gross operating margin | €-167 | €173k | |
| Total assets | €12.38M | €859k |
Show 8 other metrics
| Fiscal year | 2024 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | - |
| Net profit | €-134k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €12.38M |
| Equity | €7.93M |
| Debt | €4.44M |
| of which ≤ 1y | €1.52M |
| of which > 1y | €2.76M |
| Working capital | €-1.49M |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.02 |
| Quick ratio | 0.02 |
| Working capital ratio | -12.0% |
| Solvency | 64.1% |
| Debt / equity | 0.56 |
| Long-term debt ratio | 0.35 |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -1.1% |
| ROE | -1.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (20 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €12.38M |
| Fixed assets | 21/28 | €12.34M |
| Financial fixed assets | 28 | €12.34M |
| Current assets | 29/58 | €32k |
| Amounts receivable within one year | 40/41 | €9k |
| Cash & bank | 54/58 | €22k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €12.38M |
| Equity | 10/15 | €7.93M |
| Contributions / capital | 10/11 | €8.34M |
| Accumulated profits (losses) | 14 | €-404k |
| Amounts payable | 17/49 | €4.44M |
| Amounts payable after one year | 17 | €2.76M |
| Amounts payable within one year | 42/48 | €1.52M |
| Trade debts payable within one year | 44 | €6k |
| Income statement | ||
| Gross operating margin | 9900 | €-167 |
| Operating result | 9901 | €-229 |
| Financial charges | 65 | €134k |
| Result before taxes | 9903 | €-134k |
| Net result for the period | 9904 | €-134k |
| Result to be appropriated | 9905 | €-134k |
| NACE primary | Groothandel in farmaceutische en medische artikelen(46460) |
| Legal form | Private limited company(610) |
| Incorporation | 08-04-2022 |
| Status | Active |
| Postal code | 3590 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71011A0095/00G000 | Flanders | 7,952 m² | 1 · 1,648 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
20-06-2024 Articles of association amended, translation of the articles, coordination of the articles and amendment of specific articles
Technical details
{
"notary": {
"name": "Filip Junius",
"firm_city": null,
"firm_name": null,
"office_city": "Hasselt",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-06-20",
"filing_date": "2024-06-18",
"act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN), DOEL"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-06-18",
"unanimous": true
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"targeted_amendment",
"object_change"
],
"scope": "full_restatement",
"trigger": "wvv_adaptation",
"language_after": "nl",
"language_before": "nl"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0784.660.219",
"name_full_after": "P\u0026R Bidco",
"legal_form_after": "BESloten Vennootschap",
"name_full_before": "P\u0026R Bidco",
"current_zetel_raw": "Wetenschapspark 5 3590 Diepenbeek",
"legal_form_before": "BESloten Vennootschap"
},
"special_mandates": [
{
"holder_kbo": "0789.850.907",
"holder_name": "Euregio Law \u0026 Tax Hasselt",
"scope_categories": [
"kbo"
],
"with_substitution": true
}
],
"articles_modified": [
{
"summary": "Artikel 3 is volledig herformuleerd om het voorwerp van de vennootschap te defini\u00EBren, inclusief handelsactiviteiten, beheer van onroerend en roerend vermogen, financiering en investeringen.",
"new_text": "Artikel 3. Voorwerp\nDe vennootschap heeft tot voorwerp, zowel in Belgi\u00EB als in het buitenland:\na) de handelsvertegenwoordiging van en de handel in farmaceutische en medische producten;\nb) uitsluitend in eigen naam en voor eigen rekening: het aanleggen, het oordeelkundig uitbouwen en\nbeheren van een onroerend vermogen; alle verrichtingen, al dan niet onder het stelsel van de BTW,\nmet betrekking tot",
"change_kind": "amended",
"article_title": "Voorwerp",
"article_number": "3"
}
],
"governance_change": {
"organ_kind_after": null,
"organ_kind_before": null,
"admin_delegated_added": [
{
"name": "Euregio Law \u0026 Tax Hasselt",
"excluded_powers": []
}
],
"representation_rule_after": null,
"co_signature_threshold_eur": null,
"representation_rule_before": null
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "F. Junius",
"org_rep_person_name": null
},
"co_filed_documents": [
"een expeditie van de akte",
"een onderhandse volmacht",
"de geco\u00F6rdineerde tekst van de statuten",
"verslag van het bestuursorgaan opgesteld bij toepassing van artikel 5.101 Wetboek van vennootschappen en verenigingen"
],
"shareholder_rights": null,
"voorwerp_change_summary": "De vennootschap heeft haar voorwerp uitgebreid door artikel 3 van de statuten te wijzigen. Dit omvat de handelsvertegenwoordiging en handel in farmaceutische en medische producten, het beheer van onroerend en roerend vermogen, het aangaan van leningen en financieringen, en het beheer van investeringen in andere entiteiten.",
"capital_structure_change": null,
"coordinated_text_lineage": null
}| Legal nameNL | P&R Bidco |